Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Alert

Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

March 4, 2025

Legislation Pending: CTA Will Not Apply Against US Citizens and Domestic Reporting Companies; Filing Obligations and Penalties for Foreign Corporate Entities Remain in Place

The US Department of the Treasury has announced it will not impose any fines or penalties against US citizens, domestic reporting companies, or their beneficial owners for failure to file beneficial ownership information (BOI) reports under the Corporate Transparency Act (CTA) by existing deadlines. Furthermore, newly proposed legislation will substantially limit the CTA’s applicability to foreign reporting companies only. 

The US secretary of the treasury stated that this action was taken to ease regulatory burdens on small businesses, which are the backbone of the American economy.

Applicability of the CTA pending final legislation is as follows: 


Attorneys at Barclay Damon will continue to monitor further guidance regarding the CTA and assist clients in navigating any questions.
 
If you have any questions regarding the content of this alert, please contact Danielle Katz, counsel, at dkatz@barclaydamon.com; Karina Shahine, associate, at kshahine@barclaydamon.com; or another member of the firm’s Corporate Practice Area. 
 

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Sandra Ford, Z'Leah Liburd, Livingston Bennett, Brandi Major, and Joshua Espinal—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Year-End Focus for 403(b) Plan Sponsors: Two Critical Document Deadlines and Typical Year-End Compliance Review

Alerts

Second Circuit Reverses Award of Attorney's Fees in Coverage Dispute Between Liability Insurers

Alerts

Federal Court Narrows Scope of Insurers' Privilege Claims in COVID-19 Coverage Litigation

Alerts

AstraZeneca Escalates FARXIGA® Audit Demands: What Pharmacies Need to Know Now

Alerts

Update on the Evolving Guidance for H-1B Entry Restrictions Under September 19 Presidential Proclamation